Aspira Women’s Health (NASDAQ:AWH) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Aspira Women’s Health (NASDAQ:AWH) in a report released on Tuesday morning. The firm issued a hold rating on the stock.

Aspira Women’s Health Trading Up 2.2 %

Shares of AWH stock opened at $0.10 on Tuesday. The company has a market cap of $1.70 million, a P/E ratio of -0.08 and a beta of 1.57. The firm has a fifty day moving average price of $0.23 and a 200 day moving average price of $0.59. Aspira Women’s Health has a 12 month low of $0.08 and a 12 month high of $3.63.

Aspira Women’s Health (NASDAQ:AWH) last released its quarterly earnings data on Thursday, March 27th. The company reported ($0.08) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.21) by $0.13. The business had revenue of $2.35 million for the quarter, compared to analyst estimates of $3.00 million.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Aspira Women’s Health stock. B. Riley Wealth Advisors Inc. boosted its stake in Aspira Women’s Health Inc. (NASDAQ:AWH) by 33.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 316,294 shares of the company’s stock after acquiring an additional 79,898 shares during the period. B. Riley Wealth Advisors Inc. owned about 1.90% of Aspira Women’s Health worth $256,000 as of its most recent SEC filing. Institutional investors and hedge funds own 12.19% of the company’s stock.

About Aspira Women’s Health

Aspira Women’s Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.